{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Mycobacterium tuberculosis", "South Africa", "in vitro activity", "polyherbal medicines"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29085406", "DateCompleted": {"Year": "2018", "Month": "06", "Day": "13"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.4314/ahs.v17i3.21"], "Journal": {"ISSN": "1729-0503", "JournalIssue": {"Volume": "17", "Issue": "3", "PubDate": {"Year": "2017", "Month": "Sep"}}, "Title": "African health sciences", "ISOAbbreviation": "Afr Health Sci"}, "ArticleTitle": "Anti-mycobacterium tuberculosis activity of polyherbal medicines used for the treatment of tuberculosis in Eastern Cape, South Africa.", "Pagination": {"StartPage": "780", "EndPage": "789", "MedlinePgn": "780-789"}, "Abstract": {"AbstractText": ["The emergence of drug-resistant strains of <i>Mycobacterium tuberculosis</i> has become a global public health problem. Polyherbal medicines offer great hope for developing alternative drugs for the treatment of tuberculosis.", "To evaluate the anti-tubercular activity of polyherbal medicines used for the treatment of tuberculosis.", "The remedies were screened against <i>Mycobacterium tuberculosis</i> H37Rv using Middlebrook 7H9 media and MGIT BACTEC 960 system. They were liquid preparations from King Williams Town site A (KWTa), King Williams Town site B (KWTb), King Williams Town site C (KWTc), Hogsback first site (HBfs), Hogsback second site (HBss), Hogsback third site (HBts), East London (EL), Alice (AL) and Fort Beaufort (FB).", "The susceptibility testing revealed that all the remedies contain anti-tubercular activity with KWTa, KWTb, KWTc, HBfs, HBts, AL and FB exhibiting more activity at a concentration below 25 \u00b5l/ml. Furthermore, MIC values exhibited inhibitory activity with the most active remedies from KWTa, HBfs and HBts at 1.562 \u00b5g/ml. However, isoniazid showed more inhibitory activity against <i>M. tuberculosis</i> at 0.05 \u00b5g/ml when compare to the polyherbal remedies.", "This study has indicated that these remedies could be potential sources of new anti-mycobacterial agents against <i>M. tuberculosis</i>. However, the activity of these preparations and their active principles still require in vivo study in order to assess their future as new anti-tuberculosis agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Agriculture, University of Fort Hare, Alice 5700, South Africa."}], "LastName": "Famewo", "ForeName": "Elizabeth B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Agriculture, University of Fort Hare, Alice 5700, South Africa."}], "LastName": "Clarke", "ForeName": "Anna M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa."}], "LastName": "Wiid", "ForeName": "Ian", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa."}], "LastName": "Ngwane", "ForeName": "Andile", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 8000, South Africa."}], "LastName": "van Helden", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science and Agriculture, University of Fort Hare, Alice 5700, South Africa."}], "LastName": "Afolayan", "ForeName": "Anthony J", "Initials": "AJ"}], "PublicationTypeList": ["Evaluation Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Uganda", "MedlineTA": "Afr Health Sci", "NlmUniqueID": "101149451", "ISSNLinking": "1680-6905"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "V83O1VOZ8L", "NameOfSubstance": "Isoniazid"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": [], "DescriptorName": "Drug Contamination"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Isoniazid"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["microbiology"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "South Africa"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Tuberculosis"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Baldwin PR, Reeves AZ, Powell KR, Napier RJ, Swimm AI, Sun A, Giesler K, Bommarius B, Shinnick TM, Snyder JP, Liotta DC. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 2015;6(92):693\u2013699. doi: 10.1016/j.ejmech.2015.01.020.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.020", "PMC4794995", "25618016"]}, {"Citation": "Antony M, James J, Misra CS, Sagadevan LDM, Veettil AT, Thankamani V. Anti-mycobacterial activity of the plant extracts of Alstonia scholaris. International Journal of Current Pharmaceutical Research. 2012;4(1):40\u201342."}, {"Citation": "Tang J, Yam WC, Chen Z. Mycobacterium tuberculosis infection and vaccine development. Tuberculosis. 2016;98:30\u201341. doi: 10.1016/j.tube.2016.02.005.", "ArticleIdList": ["10.1016/j.tube.2016.02.005", "27156616"]}, {"Citation": "WHO, author. Global tuberculosis report. Geneva: World Health Organization; 2015."}, {"Citation": "Ibekwe NN, Ameh SJ. Plant natural products research in tuberculosis drug discovery and development: A situation report with focus on Nigerian biodiversity. African Journal of Biotechnology. 2015;13(23):2307\u20132320. doi: 10.5897/AJB2013.13491.", "ArticleIdList": ["10.5897/AJB2013.13491"]}, {"Citation": "Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine. 2003;163:1009\u20131021. doi: 10.1001/archinte.163.9.1009.", "ArticleIdList": ["10.1001/archinte.163.9.1009", "12742798"]}, {"Citation": "Gomez JE, McKinney JD. Mycobacterium tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004;84:29\u201344. doi: 10.1016/j.tube.2003.08.003. PubMed.", "ArticleIdList": ["10.1016/j.tube.2003.08.003", "14670344"]}, {"Citation": "Smith CV, Huang CC, Miczak A, Russell DG, Sacchettini JC, Honer zu, Bentrup K. Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. Journal of Biological Chemistry. 2003;278:1735\u20131743. doi: 10.1074/jbc.M209248200.", "ArticleIdList": ["10.1074/jbc.M209248200", "12393860"]}, {"Citation": "Shehzad A, Rehman G, Ul-Islam M, Khattak WA, Lee YS. Challenges in the development of drugs for the treatment of tuberculosis. Brazilian Journal of Infectious Diseases. 2013;17(1):74\u201381.  http://dx.doi.org/10.1016/j.bjid.2012.10.009.", "ArticleIdList": ["10.1016/j.bjid.2012.10.009", "PMC9427384", "23287547"]}, {"Citation": "Centers for Disease Control and Prevention (CDC), author Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000\u20132004. MMWR. Morbidity and mortality weekly report. 2006;55(11):301\u2013305.", "ArticleIdList": ["16557213"]}, {"Citation": "Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis [State of the art series. Drug-resistant tuberculosis. Edited by CY. Chiang. Number 1 in the series] The International Journal of Tuberculosis and Lung Disease. 2009;13(11):1320\u20131330. PubMed.", "ArticleIdList": ["19861002"]}, {"Citation": "Al-Deeb AO, Alafeefy AM. Synthesis of some new 3H-quinazolin-4-one derivatives as potential anti-tubercular agents. World Apply Science Journal. 2008;5(1):94\u201399."}, {"Citation": "Trivedi AR, Siddiqui AB, Shah VH. Design, synthesis, characterization and antitubercular activity of some 2-heterocycle-substituted phenothiazines. Arkivoc. 2008;1(2):210\u2013217. PubMed."}, {"Citation": "Islam M, Siddiqui AA, Rajesh R. Synthesis, antitubercular, antifungal and anti-bacterial activities of 6-substituted phenyl-2-(3\u00ed-substituted phenyl pyridazin-6\u00ed-yl)-2,3,4,5-tetrahydropyridazin-3-one. Acta Poloniae Pharmaceutica. 2008;65(3):353\u2013362.", "ArticleIdList": ["18646555"]}, {"Citation": "Heym B, Saint-Joanis B, Cole ST. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tubercle and Lung Disease. 1999;79:267\u2013271. doi: 10.1054/tuld.1998.0208.", "ArticleIdList": ["10.1054/tuld.1998.0208", "10692996"]}, {"Citation": "Barry CE, Lee RE, Mdluli K, Sampson AE, Schroeder BG, Slayden RA, Yuan Y. Mycolic acids: structure, biosynthesis and physiological functions. Progress in lipid research. 1998;37:143\u2013179. doi: 10.1016/S0163-7827(98)00008-3.", "ArticleIdList": ["10.1016/S0163-7827(98)00008-3", "9829124"]}, {"Citation": "Winder F. Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of mycobacteria. In: Ratledge C, Stanford J, editors. The biology of mycobacteria. Vol. 1. New York: Academic Press; 1982. pp. 354\u2013438."}, {"Citation": "Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Hatful GF, Jacobs WR Jr, editors. Molecular genetics of mycobacteria. Washington DC: ASM Press; 2000. pp. 235\u2013254."}, {"Citation": "Telenti A, Imboden P, Marchesi F. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993;341:647\u2013650. doi: 10.1016/0140-6736(93)90417-F. PubMed.", "ArticleIdList": ["10.1016/0140-6736(93)90417-F", "8095569"]}, {"Citation": "Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy. 2006;50(8):2640\u20132649. doi: 10.1128/AAC.00112-06.", "ArticleIdList": ["10.1128/AAC.00112-06", "PMC1538650", "16870753"]}, {"Citation": "Rozwarski DA, Grant GA, Barton DH, Jacobs WR, Jr, Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science. 1998;279(5347):98\u2013102. doi: 10.1126/science.279.5347.98.", "ArticleIdList": ["10.1126/science.279.5347.98", "9417034"]}, {"Citation": "Dye C, Williams BG. The population dynamics and control of tuberculosis. Science. 2010;328:856\u2013861. doi: 10.1126/science.1185449. PubMed.", "ArticleIdList": ["10.1126/science.1185449", "20466923"]}, {"Citation": "Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. Journal of Antimicrobial Chemotherapy. 2003;52:790\u2013795. doi: 10.1093/jac/dkg446.", "ArticleIdList": ["10.1093/jac/dkg446", "14563891"]}, {"Citation": "Salfinger M, Crowle AJ, Reller LB. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. Journal of Infectious Diseases. 1990;162:201\u2013207. doi: 10.1093/infdis/162.1.201.", "ArticleIdList": ["10.1093/infdis/162.1.201", "2113074"]}, {"Citation": "Zhang Y, Scorpio A, Nikaido H, Sun Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. Journal of Bacteriology. 1999;181:2044\u20132049.", "ArticleIdList": ["PMC93615", "10094680"]}, {"Citation": "Sheen P, Ferrer P, Gilman RH, L\u00f3pez-Llano J, Fuentes P, Valencia E, Zimic MJ. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis. 2009;89:109\u2013113. doi: 10.1016/j.tube.2009.01.004. PubMed.", "ArticleIdList": ["10.1016/j.tube.2009.01.004", "PMC2691962", "19249243"]}, {"Citation": "Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Medicine. 1996;2(6):662\u2013667. doi: 10.1038/nm0696-662.", "ArticleIdList": ["10.1038/nm0696-662", "8640557"]}, {"Citation": "Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nature Medicine. 1997;3(5):567\u2013570. doi: 10.1038/nm0597-567.", "ArticleIdList": ["10.1038/nm0597-567", "9142129"]}, {"Citation": "Van Niekerk C, Ginsberg A. Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes? The International Journal of Tuberculosis and Lung Disease. 2009;13:1367\u20131372.", "ArticleIdList": ["19861008"]}, {"Citation": "TB Statistics South Africa, author. TB Statistics for South Africa-National & provincial. 2015."}, {"Citation": "Hughes J, Osman M. Diagnosis and management of drug-resistant tuberculosis in South African adults. SAMJ: South African Medical Journal. 2014;104 0-0,  http://dx.doi.org/10.7196/SAMJ.9097.", "ArticleIdList": ["10.7196/SAMJ.9097"]}, {"Citation": "Bhope SG, Nagore DH, Kuber VV, Gupta PK, Patil MJ. Design and development of a stable polyherbal formulation based on the results of compatibility studies. Pharmacognosy Research. 2011;3:122. doi: 10.4103/0974-8490.81960.", "ArticleIdList": ["10.4103/0974-8490.81960", "PMC3129021", "21772756"]}, {"Citation": "Pavan FR, Leite CQF, Coelho RG, Coutinho ID, Honda NK, Cardoso CAL, Sato DN. Evaluation of anti-Mycobacterium tuberculosis activity of Campomanesia adamantium (Myrtaceae) Qu\u00edmica Nova. 2009;32:1222\u20131226. PubMed  http://dx.doi.org/10.1590/S0100-40422009000500026.", "ArticleIdList": ["10.1590/S0100-40422009000500026"]}, {"Citation": "Faizal P, Suresh S, Kumar RS, Augusti KT. A study on the hypoglycaemic and hypolipidemic effects of an ayurvedic drug Rajanyamalakadi in diabetic patients. Indian Journal of Clinical Biochemistry. 2009;24(1):82\u201387. doi: 10.1007/s12291-009-0014-1.", "ArticleIdList": ["10.1007/s12291-009-0014-1", "PMC3453461", "23105812"]}, {"Citation": "Adeneye AA, Benebo AS. Pharmacological evaluation of a Nigerian polyherbal health tonic tea in rat. African Journal of Biomedical Research. 2007;10(3)"}, {"Citation": "Gairola S, Gupta V, Bansal P, Maithani M, Krishna CM. Pharmacological activities of polyherbal formulation: Sanjivani Vati. International Journal of Ayurvedic Medicine. 2011;11(2) (1)"}, {"Citation": "Joshi CS, Priya ES, Venkataraman S. Acute and subacute toxicity studies on the polyherbal antidiabetic formulation Diakyur in experimental animal models. Journal of Health Science. 2007;53(2):245\u2013249.  http://doi.org/10.1248/jhs.53.245.", "ArticleIdList": ["10.1248/jhs.53.245"]}, {"Citation": "Gulati K, Ray A, Vijayan VK.  Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction. 2010.   http://imsear.hellis.org/handle/123456789/144975.", "ArticleIdList": ["21046988"]}, {"Citation": "Patil VP, Rajput AP, Chaudhari PM, Chaudhari SP, Baviskar DT. Pharmacological evaluation of marketed polyherbal formulation. Asian Journal of Pharmaceutical and Clinical Research. 2013;6(4):80\u201385."}, {"Citation": "Singhal S, Rathore AS, Lohar V, Dave R, Dave J. Pharmacological Evaluation of \u201cSugar Remedy,\u201d A Polyherbal Formulation, on Streptozotocin-Induced Diabetic Mellitus in Rats. Journal of Traditional and Complementary Medicine. 2014;4(3):189. doi: 10.4103/2225-4110.127800.", "ArticleIdList": ["10.4103/2225-4110.127800", "PMC4142457", "25161924"]}, {"Citation": "Green E, Samie A, Obi CL, Bessong PO, Ndip RN. Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis. Journal of Ethnopharmacology. 2010;130(1):151\u2013157. doi: 10.1016/j.jep.2010.04.033.", "ArticleIdList": ["10.1016/j.jep.2010.04.033", "20447452"]}, {"Citation": "Gupta P, Bhatter P, D'souza D, Tolani M, Daswani P, Tetali P, Birdi T. Evaluating the anti-Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays. BMC Complementary and Alternative Medicine. 2014;14:1. doi: 10.1186/1472-6882-14-84.", "ArticleIdList": ["10.1186/1472-6882-14-84", "PMC3946111", "24592852"]}, {"Citation": "Famewo EB, Clarke AM, Afolayan AJ. Identification of bacterial contaminants in polyherbal medicines used for the treatment of tuberculosis in Amatole District of the Eastern Cape Province, South Africa, using rapid 16S rRNA technique. Journal of Health, Population and Nutrition. 2016;35(1):27. doi: 10.1186/s41043-016-0064-y.", "ArticleIdList": ["10.1186/s41043-016-0064-y", "PMC5025967", "27549141"]}, {"Citation": "Famewo EB, Clarke AM, Afolayan AJ. Ethno-medicinal documentation of polyherbal medicines used for the treatment of tuberculosis in Amathole District Municipality of the Eastern Cape Province, South Africa. Pharmaceutical Biology. 2017;55(1):696\u2013700.  http://dx.doi.org/10.1080/13880209.2016.1266670.", "ArticleIdList": ["10.1080/13880209.2016.1266670", "PMC6130537", "28140734"]}, {"Citation": "Koduru S, Grierson DS, Afolayan AJ. Antimicrobial Activity of Solanum aculeastrum. Pharmaceutical Biology. 2006;44:283\u2013286. doi: 10.1080/13880200600714145.", "ArticleIdList": ["10.1080/13880200600714145"]}, {"Citation": "Askun T, Satil F, Tumen G, Yalcin O, Modanlioglu S. Antimycobacterial activity some different Lamiaceae plant extracts containing flavonoids and other phenolic compounds. INTECH Open Access Publisher; 2012."}, {"Citation": "Kirimuhuzya C, Waako P, Joloba M, Odyek O. The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda. African Health Sciences. 2009;9:40\u201345.", "ArticleIdList": ["PMC2932521", "20842241"]}, {"Citation": "Chah KF, Muko KN, Oboegbulem SI. Antimicrobial activity of methanolic extract of Solanum torvum fruit. Fitoterapia. 2000;71:187\u2013189,. doi: 10.1016/S0367-326X(99)00139-2.", "ArticleIdList": ["10.1016/S0367-326X(99)00139-2", "10727817"]}, {"Citation": "Okunade AL, Elvin-Lewis MP, Lewis WH. Natural antimycobacterial metabolites: current status. Phytochemistry. 2004;65:1017\u20131032. doi: 10.1016/j.phytochem.2004.02.013.", "ArticleIdList": ["10.1016/j.phytochem.2004.02.013", "15110681"]}, {"Citation": "Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology. 2008;46:409\u2013420. doi: 10.1016/j.fct.2007.09.085.", "ArticleIdList": ["10.1016/j.fct.2007.09.085", "17950516"]}, {"Citation": "Arunkumar S, Muthuselvam M. Analysis of phytochemical constituents and antimicrobial activities of Aloe vera L. against clinical pathogens. World Journal of Agricultural Sciences. 2009;5(5):572\u2013576."}, {"Citation": "Kose LS, Moteetee A, Van Vuuren S. Medicinal plants used for the treatment of tuberculosis in Lesotho: An ethnobotanical survey. South African Journal of Botany. 2015;98:183. doi: 10.1016/j.sajb.2015.03.059.", "ArticleIdList": ["10.1016/j.sajb.2015.03.059"]}, {"Citation": "Hannan A, Ullah MI, Usman M, Hussain S, Absar M, Javed K. Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and non-multi-drug resistant Mycobacterium tuberculosis. Pakistan Journal of Pharmaceutical Sciences. 2011;24(1):81\u201385.", "ArticleIdList": ["21190924"]}, {"Citation": "Reuter HD, Koch HP, Lawson LD. Therapeutic effects and applications of garlic and its preparations. In: Koch HP, Lawson LD, editors. Garlic: The Science and Therapeutic Application of Allium sativum L. Baltimore, MD, USA: Williams and Wilkins; 1996. pp. 135\u2013512."}, {"Citation": "Viswanathan V, Phadatare AG, Mukne A. Antimycobacterial and antibacterial activity of Allium sativum bulbs. Indian Journal of Pharmaceutical Sciences. 2014 doi: 10.4103/0250-474X.135018.", "ArticleIdList": ["10.4103/0250-474X.135018", "PMC4090836", "25035540"]}, {"Citation": "Samie A, Tambani T, Harshfield E, Green E, Ramalivhana JN, Bessong PO. Antifungal activities of selected Venda medicinal plants against Candida albicans, Candida krusei and Cryptococcus neoformans isolated from South African AIDS patients. African Journal of Biotechnology. 2010;17(9) (20)"}, {"Citation": "Fitzpatrick FK. Plant substances active against Mycobacterium tuberculosis. Antibiotics and Chemotherapy. 1954;4:528\u2013536. PubMed.", "ArticleIdList": ["24543026"]}, {"Citation": "Lawal IO, Grierson DS, Afolayan AJ. Phytotherapeutic information on plants used for the treatment of tuberculosis in Eastern Cape Province, South Africa. Evidence-Based Complementary and Alternative Medicine. 2014;22 2014,  http://dx.doi.org/10.1155/2014/735423.", "ArticleIdList": ["10.1155/2014/735423", "PMC4016884", "24864158"]}, {"Citation": "Ahmed AA, Bishr MM, El-Shanawany MA, Attia EZ, Ross SA, Par\u00e9 PW. Rare trisubstituted sesquiterpenes daucanes from the wild Daucus carota. Phytochemistry. 2005;66(14):1680\u20131684. doi: 10.1016/j.phytochem.2005.05.010.", "ArticleIdList": ["10.1016/j.phytochem.2005.05.010", "15964039"]}, {"Citation": "Majumder PK, Dasgupta S, Mukhopadhaya RK, Mazumdar UK, Gupta M. Anti-steroidogenic activity of the petroleum ether extract and fraction 5 (fatty acids) of carrot (Daucus carota L.) seeds in mouse ovary. Journal of Ethnopharmacology. 1997;57(3):209\u2013212. doi: 10.1016/S0378-8741(97)00056-1.", "ArticleIdList": ["10.1016/S0378-8741(97)00056-1", "9292415"]}, {"Citation": "Arabshahi D S, Devi DV, Urooj A. Evaluation of antioxidant activity of some plant extracts and their heat, pH and storage stability. Food Chemistry. 2007;100(3):1100\u20131115. doi: 10.1016/j.foodchem.2005.11.014.", "ArticleIdList": ["10.1016/j.foodchem.2005.11.014"]}, {"Citation": "Ghisalberti EL. The daucane (carotane) class of sesquiterpenes. Phytochemistry. 1994;37(3):597\u2013623. doi: 10.1016/S0031-9422(00)90327-3.", "ArticleIdList": ["10.1016/S0031-9422(00)90327-3"]}, {"Citation": "Foster S, Duke JA. A field guide to medicinal plants and herbs of eastern and central North America. Houghton Mifflin Harcourt; 2000."}, {"Citation": "Porchezhian E, Ansari SH, Ali M. Analgesic and anti-inflammatory activity of volatile oil from Daucus carota Linn seeds. Indian Journal of Natural Products. 2000;16(1):24\u201326."}, {"Citation": "Bishayee A, Sarkar A, Chatterjee M. Hepatoprotective activity of carrot (Daucus carota L.) against carbon tetrachloride intoxication in mouse liver. Journal of Ethnopharmacology. 1995;47(2):69\u201374. doi: 10.1016/0378-8741(95)01254-B.", "ArticleIdList": ["10.1016/0378-8741(95)01254-B", "7500638"]}, {"Citation": "Sharma KD, Karki S, Thakur NS, Attri S. Chemical composition, functional properties and processing of carrot\u2014a review. Journal of Food Science and Technology. 2012;49(1):22\u201332. doi: 10.1007/s13197-011-0310-7.", "ArticleIdList": ["10.1007/s13197-011-0310-7", "PMC3550877", "23572822"]}, {"Citation": "Ker JA. Ventricular tachycardia as an adverse effect of the African Potato (Hypoxis sp.). Cardiovascular journal of South Africa. Official Journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners. 2005;16(1):55. PubMed.", "ArticleIdList": ["15778774"]}, {"Citation": "Buwa LV, Van Staden J. Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. Journal of Ethnopharmacology. 2006;103(1):139\u2013142. doi: 10.1016/j.jep.2005.09.020.", "ArticleIdList": ["10.1016/j.jep.2005.09.020", "16271287"]}, {"Citation": "Steenkamp V, Gouws MC. Cytotoxicity of six South African medicinal plant extracts used in the treatment of cancer. South African Journal of Botany. 2006;72(4):630\u2013633. doi: 10.1016/j.sajb.2006.02.004.", "ArticleIdList": ["10.1016/j.sajb.2006.02.004"]}, {"Citation": "Steenkamp V, Gouws MC, Gulumian M, Elgorashi EE, Van Staden J. Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis. Journal of Ethnopharmacology. 2006;103(1):71\u201375. doi: 10.1016/j.jep.2005.07.007.", "ArticleIdList": ["10.1016/j.jep.2005.07.007", "16122891"]}, {"Citation": "Drewes SE, Hall AJ, Learmonth RA, Upfold UJ. Isolation of hypoxoside from Hypoxis rooperi and synthesis of (E)-1, 5-bis (3\u2032, 4\u2032-dimethoxyphenyl) pent-4-en-1-yne. Phytochemistry. 1984;23(6):1313\u20131316. doi: 10.1016/S0031-9422(00)80449-5. PubMed.", "ArticleIdList": ["10.1016/S0031-9422(00)80449-5"]}, {"Citation": "Ncube B, Ndhlala AR, Okem A, Van Staden J. Hypoxis (Hypoxidaceae) in African traditional medicine. Journal of Ethnopharmacology. 2013;50(3):818\u2013827. doi: 10.1016/j.jep.2013.10.032.", "ArticleIdList": ["10.1016/j.jep.2013.10.032", "24184189"]}, {"Citation": "Lall N, Meyer JJ. In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. Journal of Ethnopharmacology. 1999;66(3):347\u2013354. doi: 10.1016/S0378-8741(98)00185-8.", "ArticleIdList": ["10.1016/S0378-8741(98)00185-8", "10473184"]}, {"Citation": "Dzoyem JP, Aro AO, McGaw LJ, Eloff JN. Antimycobacterial activity against different pathogens and selectivity index of fourteen medicinal plants used in Southern Africa to treat tuberculosis and respiratory ailments. South African Journal of Botany. 2016;31(102):70\u201374. doi: 10.1016/j.sajb.2015.08.002.", "ArticleIdList": ["10.1016/j.sajb.2015.08.002"]}]}], "History": [{"Year": "2017", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29085406", "PMC5656206", "10.4314/ahs.v17i3.21", "jAFHS.v17.i3.pg780"]}}]}